Biotech Firm Finds Reverse Osmosis Preferable to Distillation for Production of Water for Injection 

Water Technologies
  • English
X

Contact


search

  • Home
    • Product Groups
    • Market-specific Solutions
    • Investor Relations
    • Press
    • Jobs & Careers
    • Sustainability
    • About Us
    • Industry Sector
    • Energy Sector
    • Healthcare Sector
  • Market-specific Solutions
    • Automotive
    • Chemicals
    • Construction and Real Estate
    • Finance
    • Food&Beverage
    • Machine Building
    • Metals & Mining
    • Oil & Gas
    • Pharmaceuticals
    • Public Sector
    • Pulp & Paper
    • Tourism & Leisure
    • Transportaion & Logistics
    • Water
    • Wholesale / Retail
    • Cross Market Offerings
  • Water Technologies
    • Products
    • Services
    • Parts
    • Food and Beverage Industry
    • Life Sciences Industry
    • Marine Industry
    • Mining Industry
    • Oil and Gas Industry
    • Power Industry
    • Semiconductor and Solar Industry
    • Municipal
    • Aquatics and Leisure
    • Applications
    • About Us
    • Videos
    • Site Map
  • Applications
    • Aquatic Water Treatment
    • Corrosion and Biofouling Protection
    • Drinking Water Treatment
    • Groundwater Remediation
    • High Purity Water
    • Industrial Process Water
    • Odor and Vapor Control
    • Oil & Gas Produced Water
    • Sludge & Biosolids Treatment
    • Wastewater Treatment
    • Water Recycle & Reuse
    • Water and Wastewater Library
    • Find a Case Study
  • High Purity Water

Biotech Firm Finds Reverse Osmosis Preferable to Distillation for Production of Water for Injection

Challenge

A Biotech firm on the West Coast has found that certain cell cultures fare poorly in distilled water, yet thrive in reverse osmosis water. Another requirement is to optimize water conservation.

Solution

Siemens Water Technologies engineered a novel design, including reverse osmosis, service deionization, and a second pass reverse osmosis.

The RO/SDI/RO system is hot water sanitizable to assure ultra-low microbial counts. The FDA has historically required two passes of reverse osmosis to produce WFI. The first pass RO / SDI produces USP Purified Water. A portion of this water feeds the second (single pass) RO to produce WFI.

The second RO runs at effectively 100% recovery (the entire waste stream is recycled back to the pretreatment breaktank). The recovery at the membrane surface is low to minimize fouling and maintenance while assuring product water quality.

Results

  • Cell culture process yield is optimal
  • Quality – the system consistently exceeds the requirements for WFI.
  • The price of the second RO was about half of the cost of a still.
  • Operating costs - Steam savings of 98% compared to that of a still
  • Saves 1.3 million gallons per year in water and sewer charges compared to a still

top of page
Print
Contact Us
Get help now
Contact

Related Service

Service Deionization

Sign up for our FREE newsletter.
First Name:
Email:
We respect your privacy and will never sell or rent our subscriber list.
© Siemens AG 2011 - Water Technologies
Corporate Information | Privacy Policy | Terms Of Use | Digital ID